The U.S. government has awarded Kernal Bio and three other sub-awardees up to $48 million to help advance the biotech’s in vivo mRNA-encoded CAR T-cell program. In an interesting—if not somewhat ...

Various organizations in Northern Indiana and Michigan are offering yoga, fitness and wellness classes. Free assistance and educational sessions for Medicare Open Enrollment are available through ...

The Illini were back in action at the Joe Piane Notre Dame Invitational Friday. It was their first away race of the season after competing in the Fighting Illini Invitational at the end of August.

CORPUS CHRISTI, Texas — The holiday season is officially underway for The Salvation Army of the Coastal Bend, as the organization kicks off its annual Angel Tree program—a beloved tradition that ...

Trumpf has developed laser applications for adhesive and coating preparation in battery production and for corrosion protection of aluminum components. The high-tech company is thus making electric ...

General Motors has canceled its next-generation hydrogen fuel cell development efforts and scrapped a planned $55 million factory in Detroit after determining no path forward for the nascent ...

General Motors Co. is scrapping plans for a factory in Detroit as part of a broader decision to end development of hydrogen fuel cells for everyday drivers, the automaker said Friday. Salaried workers ...

SOUTH BEND ― You don’t have to wander Rolfs Hall long to realize that much about Notre Dame women’s basketball is different. Don’t climb the steps to the second-floor conference room where the coaches ...

No. 7 Indiana, college football's losingest program historically, landed its biggest road win — maybe its biggest win, period — Saturday afternoon, knocking off No. 2 Oregon 30-20 at Autzen Stadium in ...

Over Indiana's final nine games last year, Shay Ciezki averaged 15.6 points per game while shooting 53.1% from 3-point range. Ciezki is the lone returning starter for a Hoosiers team that added nine ...

Exclusive commercial rights secured for the nanobody-based CD22 binder for next-generation CAR applications like in vivo CAR-T and CAR-M CD22 nanobody binder offers potential advantages compared to ...